REFERENCES
Becker C, Fantini MC, Neurath MF (2006). High resolution colonoscopy in
live mice. Nat Protoc 1 (6): 2900-2904.
Bhat P, Leggatt G, Waterhouse N, Frazer IH (2017). Interferon-gamma
derived from cytotoxic lymphocytes directly enhances their motility and
cytotoxicity. Cell Death Dis 8 (6): e2836.
Camuesco D, Rodriguez-Cabezas ME, Garrido-Mesa N, Cueto-Sola M, Bailon
E, Comalada M, et al. (2012). The intestinal anti-inflammatory
effect of dersalazine sodium is related to a down-regulation in IL-17
production in experimental models of rodent colitis. Br J
Pharmacol 165 (3): 729-740.
Carethers JM, Jung BH (2015). Genetics and Genetic Biomarkers in
Sporadic Colorectal Cancer. Gastroenterology149 (5): 1177-1190 e1173.
Clarke WT, Feuerstein JD (2019). Colorectal cancer surveillance in
inflammatory bowel disease: Practice guidelines and recent developments.World J Gastroenterol 25 (30): 4148-4157.
Colombo F, Illescas O, Noci S, Minnai F, Pintarelli G, Pettinicchio
A, et al. (2022). Gut microbiota composition in colorectal cancer
patients is genetically regulated. Sci Rep12 (1): 11424.
Das PK, Islam F, Lam AK (2020). The Roles of Cancer Stem Cells and
Therapy Resistance in Colorectal Carcinoma. Cells 9 (6).
Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J (2017).
MicrobiomeAnalyst: a web-based tool for comprehensive statistical,
visual and meta-analysis of microbiome data. Nucleic Acids Res45 (W1): W180-W188.
Dongre A, Weinberg RA (2019). New insights into the mechanisms of
epithelial-mesenchymal transition and implications for cancer. Nat
Rev Mol Cell Biol 20 (2): 69-84.
Fearon ER, Vogelstein B (1990). A genetic model for colorectal
tumorigenesis. Cell 61 (5): 759-767.
Fong W, Li Q, Yu J (2020). Gut microbiota modulation: a novel strategy
for prevention and treatment of colorectal cancer. Oncogene39 (26): 4925-4943.
Garrett WS (2019). The gut microbiota and colon cancer. Science364 (6446): 1133-1135.
Garrido-Mesa J, Rodriguez-Nogales A, Algieri F, Vezza T, Hidalgo-Garcia
L, Garrido-Barros M, et al. (2018). Immunomodulatory
tetracyclines shape the intestinal inflammatory response inducing
mucosal healing and resolution. Br J Pharmacol175 (23): 4353-4370.
Ghanem S, Kim CJ, Dutta D, Salifu M, Lim SH (2021). Antimicrobial
therapy during cancer treatment: Beyond antibacterial effects. J
Intern Med 290 (1): 40-56.
Hou X, Zhang P, Du H, Chu W, Sun R, Qin S, et al. (2021).
Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in
Colon Cancer. Front Pharmacol 12: 725583.
Hu H, Dong Z, Tan P, Zhang Y, Liu L, Yang L, et al. (2016).
Antibiotic drug tigecycline inhibits melanoma progression and metastasis
in a p21CIP1/Waf1-dependent manner. Oncotarget7 (3): 3171-3185.
Ibrahim A, Hugerth LW, Hases L, Saxena A, Seifert M, Thomas Q, et
al. (2019). Colitis-induced colorectal cancer and intestinal epithelial
estrogen receptor beta impact gut microbiota diversity. Int J
Cancer 144 (12): 3086-3098.
Kalkavan H, Green DR (2018). MOMP, cell suicide as a BCL-2 family
business. Cell Death Differ 25 (1): 46-55.
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993).
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early
marker of chemotherapy-induced apoptosis. Cancer Res53 (17): 3976-3985.
Kawada M, Seno H, Uenoyama Y, Sawabu T, Kanda N, Fukui H, et al.(2006). Signal transducers and activators of transcription 3 activation
is involved in nuclear accumulation of beta-catenin in colorectal
cancer. Cancer Res 66 (6): 2913-2917.
Koh GY, Kane AV, Wu X, Crott JW (2020). Parabacteroides distasonis
attenuates tumorigenesis, modulates inflammatory markers and promotes
intestinal barrier integrity in azoxymethane-treated A/J mice.Carcinogenesis 41 (7): 909-917.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler
KW, et al. (1997). Constitutive transcriptional activation by a
beta-catenin-Tcf complex in APC-/- colon carcinoma. Science275 (5307): 1784-1787.
Kroon AM, Dontje BHJ, Holtrop M, Van Den Bogert C (1984). The
mitochondrial genetic system as a target for chemotherapy: Tetracyclines
as cytostatics. Cancer Letters 25 (1): 33-40.
Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A,
Martinez-Outschoorn UE, et al. (2015). Antibiotics that target
mitochondria effectively eradicate cancer stem cells, across multiple
tumor types: treating cancer like an infectious disease.Oncotarget 6 (7): 4569-4584.
Li H, Jiao S, Li X, Banu H, Hamal S, Wang X (2015). Therapeutic effects
of antibiotic drug tigecycline against cervical squamous cell carcinoma
by inhibiting Wnt/beta-catenin signaling. Biochem Biophys Res
Commun 467 (1): 14-20.
Li H, Zhu H, Xu C-j, Yuan J (1998). Cleavage of BID by Caspase 8
Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis.Cell 94 (4): 491-501.
Ling A, Lundberg IV, Eklof V, Wikberg ML, Oberg A, Edin S, et al.(2016). The infiltration, and prognostic importance, of Th1 lymphocytes
vary in molecular subgroups of colorectal cancer. J Pathol Clin
Res 2 (1): 21-31.
Lopez-Siles M, Martinez-Medina M, Suris-Valls R, Aldeguer X, Sabat-Mir
M, Duncan SH, et al. (2016). Changes in the Abundance of
Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal
Mucosa of Inflammatory Bowel Disease and Patients with Colorectal
Cancer. Inflamm Bowel Dis 22 (1): 28-41.
Love MI, Huber W, Anders S (2014). Moderated estimation of fold change
and dispersion for RNA-seq data with DESeq2. Genome Biol15 (12): 550.
Lu R, Zhang YG, Sun J (2017). STAT3 activation in infection and
infection-associated cancer. Mol Cell Endocrinol 451:80-87.
Luo J, Yan R, He X, He J (2017). Constitutive activation of STAT3 and
cyclin D1 overexpression contribute to proliferation, migration and
invasion in gastric cancer cells. Am J Transl Res9 (12): 5671-5677.
Malinowsky K, Nitsche U, Janssen KP, Bader FG, Spath C, Drecoll E,
et al. (2014). Activation of the PI3K/AKT pathway correlates with
prognosis in stage II colon cancer. Br J Cancer110 (8): 2081-2089.
Mirzaei R, Afaghi A, Babakhani S, Sohrabi MR, Hosseini-Fard SR,
Babolhavaeji K, et al. (2021). Role of microbiota-derived
short-chain fatty acids in cancer development and prevention.Biomed Pharmacother 139: 111619.
Raskov H, Orhan A, Christensen JP, Gogenur I (2021). Cytotoxic CD8(+) T
cells in cancer and cancer immunotherapy. Br J Cancer124 (2): 359-367.
Revathidevi S, Munirajan AK (2019). Akt in cancer: Mediator and more.Semin Cancer Biol 59: 80-91.
Saikali Z, Singh G (2003). Doxycycline and other tetracyclines in the
treatment of bone metastasis. Anti-cancer drugs 14:773-778.
Sen S, Carmagnani Pestana R, Hess K, Viola GM, Subbiah V (2018). Impact
of antibiotic use on survival in patients with advanced cancers treated
on immune checkpoint inhibitor phase I clinical trials. Ann Oncol29 (12): 2396-2398.
Shang S, Hua F, Hu ZW (2017). The regulation of beta-catenin activity
and function in cancer: therapeutic opportunities. Oncotarget8 (20): 33972-33989.
Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolfi
S, et al. (2012). beta-catenin confers resistance to PI3K and AKT
inhibitors and subverts FOXO3a to promote metastasis in colon cancer.Nat Med 18 (6): 892-901.
Terzic J, Grivennikov S, Karin E, Karin M (2010). Inflammation and colon
cancer. Gastroenterology 138 (6): 2101-2114
e2105.
Tjalsma H, Boleij A, Marchesi JR, Dutilh BE (2012). A bacterial
driver-passenger model for colorectal cancer: beyond the usual suspects.Nat Rev Microbiol 10 (8): 575-582.
Tolomeo M, Grimaudo S, Milano S, La Rosa M, Ferlazzo V, Di Bella
G, et al. (2001). Effects of chemically modified tetracyclines
(CMTs) in sensitive, multidrug resistant and apoptosis resistant
leukaemia cell lines. Br J Pharmacol 133 (2):306-314.
Waetzig V, Herdegen T (2003). A single c-Jun N-terminal kinase isoform
(JNK3-p54) is an effector in both neuronal differentiation and cell
death. J Biol Chem 278 (1): 567-572.
Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, et al. (2021).
Identification of microbial markers across populations in early
detection of colorectal cancer. Nat Commun12 (1): 3063.
Xie YH, Chen YX, Fang JY (2020). Comprehensive review of targeted
therapy for colorectal cancer. Signal Transduct Target Ther5 (1): 22.
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, et al.(2008). Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell
cycle arrest, and reduces tumor cell invasion in colorectal cancer
cells. Neoplasia 10 (3): 287-297.
Yang J, McDowell A, Kim EK, Seo H, Lee WH, Moon CM, et al.(2019). Development of a colorectal cancer diagnostic model and dietary
risk assessment through gut microbiome analysis. Exp Mol Med51 (10): 1-15.
Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C (2019). Strain-Specific
Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on
Chronic Colitis in Mice. Front Cell Infect Microbiol 9:239.
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, et al. (2018). The
lncRNA NEAT1 activates Wnt/beta-catenin signaling and promotes
colorectal cancer progression via interacting with DDX5. J Hematol
Oncol 11 (1): 113.
Zhou W, Lv R, Qi W, Wu D, Xu Y, Liu W, et al. (2014). Snail
contributes to the maintenance of stem cell-like phenotype cells in
human pancreatic cancer. PLoS One 9 (1): e87409.